An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer

References

• Barnett R Historical keyword: diabetes Lancet 2010 375 9710 191 20109909
   PubMed Web of Science ®Google Scholar
• Torpy JM Lynm C Glass RM JAMA patient page: diabetes JAMA 2009 301 15 1620 19366784
   PubMedGoogle Scholar
• Barbeau WE Bassaganya-Riera J Hontecillas R Putting the pieces of the puzzle together – a series of hypotheses on the etiology and pathogenesis of type 1 diabetes Med Hypotheses 2007 68 3 607 619 17045415
   PubMed Web of Science ®Google Scholar
• Moore PA Zgibor JC Dasanayake AP Diabetes: a growing epidemic of all ages J Am Dent Assoc 2003 134 Spec No 11S 15S 18196668
   PubMedGoogle Scholar
• Larsen N Vogensen FK van den Berg FW Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults PLoS One 2010 5 2 e9085 20140211
   PubMed Web of Science ®Google Scholar
• Johansen JS Harris AK Rychly DJ Ergul A Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice Cardiovasc Diabetol 2005 4 1 5 15862133
   PubMed Web of Science ®Google Scholar
• Cani PD Neyrinck AM Fava F Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia Diabetologia 2007 50 11 2374 2383 17823788
   PubMed Web of Science ®Google Scholar
• Heel RC Brogden RN Speight TM Avery GS Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia Drugs 1978 15 6 409 428 350557
   PubMed Web of Science ®Google Scholar
• Zimetbaum P Eder H Frishman W Probucol: pharmacology and clinical application J Clin Pharmacol 1990 30 1 3 9 2406299
   PubMed Web of Science ®Google Scholar
• Yamashita S Matsuzawa Y Where are we with probucol: a new life for an old drug? Atherosclerosis 2009 207 1 16 23 19457483
   PubMed Web of Science ®Google Scholar
• Crim WS Wu R Carter JD AGI-1067, a novel antioxidant and anti-inflammatory agent, enhances insulin release and protects mouse islets Mol Cell Endocrinol 2010 323 2 246 255 20211684
   PubMed Web of Science ®Google Scholar
• Karunakaran U Park KG A systematic review of oxidative stress and safety of antioxidants in diabetes: focus on islets and their defense Diabetes Metab J 2013 37 2 106 112 23641350
   PubMedGoogle Scholar
• Takatori A Ohta E Inenaga T Protective effects of probucol treatment on pancreatic beta-cell function of SZ-induced diabetic APA hamsters Exp Anim 2003 52 4 317 327 14562608
   PubMed Web of Science ®Google Scholar
• Gorogawa S Kajimoto Y Umayahara Y Probucol preserves pancreatic beta-cell function through reduction of oxidative stress in type 2 diabetes Diabetes Res Clin Pract 2002 57 1 1 10 12007724
   PubMed Web of Science ®Google Scholar
• Russell JC Graham SE Amy RM Dolphin PJ Cardioprotective effect of probucol in the atherosclerosis-prone JCR:LA-cp rat Eur J Pharmacol 1998 350 2–3 203 210 9696409
   PubMed Web of Science ®Google Scholar
• Palin KJ Wilson CG The effect of different oils on the absorption of probucol in the rat J Pharm Pharmacol 1984 36 9 641 643 6149296
   PubMed Web of Science ®Google Scholar
• Tanaka Y Inkyo M Yumoto R Nagai J Takano M Nagata S Nanoparticulation of probucol, a poorly water-soluble drug, using a novel wet-milling process to improve in vitro dissolution and in vivo oral absorption Drug Dev Ind Pharm 2012 38 8 1015 1023 22118063
   PubMed Web of Science ®Google Scholar
• Heeg JF Hiser MF Satonin DK Rose JQ Pharmacokinetics of probucol in male rats J Pharm Sci 1984 73 12 1758 1763 6527251
   PubMed Web of Science ®Google Scholar
• Lalic-Popovic M Vasovic V Milijasevic B Golocorbin-Kon S Al-Salami H Mikov M Deoxycholic acid as a modifier of the permeation of gliclazide through the blood–brain barrier of a rat J Diabetes Res 2013 2013 598603 23671878
   PubMed Web of Science ®Google Scholar
• Negrulj R Mooranian A Al-Salami H Potentials and limitations of bile acids in type 2 diabetes mellitus: applications of microencapsulation as a novel oral delivery system Journal of Endocrinology and Diabetes Mellitus 2013 1 2 49 59
   Google Scholar
• Whelehan M Marison IW Microencapsulation using vibrating technology J Microencapsul 2011 28 8 669 688 22047545
   PubMed Web of Science ®Google Scholar
• Al-Salami H Butt G Fawcett JP Tucker IG Golocorbin-Kon S Mikov M Probiotic treatment reduces blood glucose and increases systemic absorption of gliclazide in diabetic rats Eur J Drug Metab Pharmacokinet 2008 32 2 101 106 18777945
   PubMed Web of Science ®Google Scholar
• Al-Salami H Butt G Tucker I Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats Eur J Drug Metab Pharmacokinet 2009 34 1 43 50 19462928
   PubMed Web of Science ®Google Scholar
• Al-Salami H Butt G Tucker I Mikov M Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics Methods Find Exp Clin Pharmacol 2008 30 2 107 113 18560625
   PubMedGoogle Scholar
• Al-Salami H Butt G Tucker IG Mikov M The influence of probiotic pretreatment on the ilealpermeation of gliclazide in healthy and diabetic rats Arch Drug lnf 2008 1 1 35 41
   PubMedGoogle Scholar
• Al-Salami H Butt G Tucker I Skrbic R Golocorbin-Kon S Mikov M Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats Arch Drug Inf 2008 1 1 35 41 20157366
   PubMedGoogle Scholar
• Mooranian A Negrulj R Mathavan S A complex microencapsulated system: a platform for optimized oral delivery of antidiabetic drug–bile acid formulations Pharm Dev Technol Epub 2014 5 5
   Web of Science ®Google Scholar
• Mooranian A Negrulj R Chen-Tan N Microencapsulation as a novel delivery method for the potential antidiabetic drug, probucol Drug Des Devel Ther 2014
   Web of Science ®Google Scholar
• Mooranian A Negrulj R Mathavan S Stability and release kinetics of an advanced gliclazide–cholic acid formulation: the use of artificial-cell microencapsulation in slow release targeted oral delivery of antidiabetics J Pharm Innov 2014 9 150 157 24829616
   PubMed Web of Science ®Google Scholar
• Mooranian A Negrulja R Chen-Tan N Novel artificial cell microencapsulation of a complex gliclazide–deoxycholic bile acid formulation: a characterization study Drug Des Devel Ther 2014 8 1003 1112
   PubMed Web of Science ®Google Scholar
• Tam SK Dusseault J Polizu S Menard M Halle JP Yahia L Physicochemical model of alginate–poly-L-lysine microcapsules defined at the micrometric/nanometric scale using ATR-FTIR, XPS, and ToF-SIMS Biomaterials 2005 26 34 6950 6961 15975648
   PubMed Web of Science ®Google Scholar
• Davignon J Probucol Schettler G Habenicht AJR Principles and Treatment of Lipoprotein Disorders Berlin Springer 1994 429 469
   Google Scholar
• George M Abraham TE Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan – a review J Control Release 2006 114 1 1 14 16828914
   PubMed Web of Science ®Google Scholar
• Kandrac J Kevresan S Gu JK Mikov M Fawcett JP Kuhajda K Isolation and determination of bile acids Eur J Drug Metab Pharmacokinet 2006 31 3 157 177 17136860
   PubMed Web of Science ®Google Scholar
• Kuhajda K Kandrac J Kevresan S Mikov M Fawcett JP Structure and origin of bile acids: an overview Eur J Drug Metab Pharmacokinet 2006 31 3 135 143 17136858
   PubMed Web of Science ®Google Scholar
• Takka S Cali AG Bile salt-reinforced alginate–chitosan beads Pharm Dev Technol 2012 17 1 23 29 20653409
   PubMed Web of Science ®Google Scholar
• Yang Y Campanella OH Hamaker BR Zhang G Gu Z Rheological investigation of alginate chain interactions induced by concentrating calcium cations Food Hydrocoll 2013 30 1 26 32
   Web of Science ®Google Scholar
• Bonino CA Samorezov JE Jeon O Alsberg E Khan SA Real-time in situ rheology of alginate hydrogel photocrosslinking Soft Matter 2011 7 24 11510 11517
   Web of Science ®Google Scholar
• de Celis Alonso B Rayment P Ciampi E NMR relaxometry and rheology of ionic and acid alginate gels Carbohydr Polym 2010 82 3 663 669
   Web of Science ®Google Scholar
• Draget KI Taylor C Chemical, physical, and biological properties of alginates and their biomedical implications Food Hydrocoll 2011 25 2 251 256
   Web of Science ®Google Scholar
• Pamies R Rodriguez Schmidt R Lopez Martinez MDC Garcia de la Torre J The influence of mono and divalent cations on dilute and non-dilute aqueous solutions of sodium alginates Carbohydr Polym 2010 80 1 248 253
   Web of Science ®Google Scholar
• Legrand J Dumont E Comiti J Fayolle F Diffusion coefficients of ferricyanide ions in polymeric solutions – comparison of different experimental methods Electrochim Acta 2000 45 11 1791 1803
   Web of Science ®Google Scholar
• Sarmento B Ferreira D Veiga F Ribeiro A Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies Carbohydr Polym 2006 66 1 1 7
   Web of Science ®Google Scholar
• Gill P Moghadam TT Ranjbar B Differential scanning calorimetry techniques: applications in biology and nanoscience J Biomol Tech 2010 21 4 167 193 21119929
   PubMedGoogle Scholar
• Ajun W Yan S Li G Huili L Preparation of aspirin and probucol in combination loaded chitosan nanoparticles and in vitro release study Carbohydr Polym 2009 75 4 566 574
   Web of Science ®Google Scholar
• Thybo P Pedersen BL Hovgaard L Holm R Mullertz A Characterization and physical stability of spray dried solid dispersions of probucol and PVP-K30 Pharm Dev Technol 2008 13 5 375 386 18720236
   PubMed Web of Science ®Google Scholar
• Soares JP Santos JE Chierice GO Cavalheiro ETG Thermal behavior of alginic acid and its sodium salt Ecletica Quimica 2004 29 2 57 64
   Google Scholar
• Mooranian A Negruli R Mathavan S Stability and release kinetics of an advanced gliclazide–cholic acid formulation: the use of artificial-cell microencapsulation in slow release targeted oral delivery of antidiabetics J Pharm Innov 2014 9 150 157 24829616
   PubMed Web of Science ®Google Scholar
• Kulkarni AR Soppimath KS Aminabhavi TM Rudzinski WE In-vitro release kinetics of cefadroxil-loaded sodium alginate interpenetrating network beads Eur J Pharm Biopharm 2001 51 2 127 133 11226819
   PubMed Web of Science ®Google Scholar